Acurx Pharmaceuticals, Inc. 10-Q filing
Filed 2026-05-11 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001104659-26-058631
- Form type
- 10-Q
- CIK
- 0001736243
- Primary document
- https://www.sec.gov/Archives/edgar/data/1736243/000110465926058631/acxp-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Acurx Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-1.7M | - | - |
| Net Income | $-1.7M | - | - |
| Eps Basic | -0.62 | - | - |
| Eps Diluted | -0.62 | - | - |
| Total Assets | $9.5M | - | - |
| Total Liabilities | $2.5M | - | - |
| Shareholders Equity | $7.0M | - | - |
| Operating Cash Flow | $-1.4M | - | - |